to respond to the COVID-19 pandemic by developing a SARS-CoV-2 vaccine evaluated through Phase 1 clinical testing
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-016076
Grant search
Key facts
Disease
COVID-19Start & end year
2020Known Financial Commitments (USD)
$4,019,427Funder
Gates FoundationResearch Location
IndiaLead Research Institution
Biological E. LimitedResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Phase 1 clinical trialSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Clinical Trial, Phase IBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
N/A